Puma Biotechnology (PBYI) Stock Price, Quote, News & History

Comments

Puma Biotechnology Inc (PBYI) Stock Price, Quote, News & History

PBYINASDAQ

Trade with Public

$6.12

-0.03-0.49%

At close: Mar 20, 5:00 PM EST

$6.12

N/A

After Hours: 4:00 PM EST

OverviewNews Earnings Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Key Statistics

Open

$6.14

Close

$6.12

Volume / Avg.

340.27K / 430.72K

Day Range

$6.07 - $6.17

52 Wk Range

2.58 - 7.68

Market Cap

$308.39M

P/E Ratio

10.08

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

8.73%

Days to Cover

7.5

Recent Puma Biotechnology Inc News

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings

Vandana Singh

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

41.80M

Investing Cash Flow (TTM)

-36.19M

Financing Cash Flow (TTM)

-45.20M

Free Cash Flow (TTM)

41.73M

Capital Expenditure (TTM)

-71.00K

Net Change in Cash (TTM)

-39.58M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$243.91M

PE Ratio (TTM)

10.08

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.36

PB Ratio (TTM)

2.40

Earnings Yield % (TTM)

9.92%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

4.57

Price / EBITDA (TTM)

5.84

Price / Free Cash Flow (TTM)

7.46

Book Value / Share

$2.56

Company Debt

Total Debt

$22.52M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$44.44M

Total Cash

$29.64M

Debt to Equity

0.22

Issuance of Debt (TTM)

-$44.44M

Repayment of Debt (TTM)

-$44.44M

Key Statistics

Open

$6.14

Close

$6.12

Volume / Avg.

340.27K / 430.72K

Day Range

$6.07 - $6.17

52 Wk Range

2.58 - 7.68

Market Cap

$308.39M

P/E Ratio

10.08

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

8.73%

Days to Cover

7.5

About

Sector

Health Care

Industry

Biotechnology

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Puma Biotechnology (PBYI) stock?

A

You can purchase shares of Puma Biotechnology (NASDAQ:PBYI) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Puma Biotechnology (PBYI) competitors?

A

Other companies in Puma Biotechnology’s space includes: Cabaletta Bio Inc (NASDAQ:CABA), Immuneering Corp (NASDAQ:IMRX), PepGen Inc (NASDAQ:PEPG), Armata Pharmaceuticals Inc (AMEX:ARMP) and Palisade Bio Inc (NASDAQ:PALI).

Q

What is the forecast, or price target, for Puma Biotechnology (PBYI) stock?

A

Puma Biotechnology has a consensus price target of $7.00.

Q

What is the current price for Puma Biotechnology (PBYI)?

A

The stock price for Puma Biotechnology (NASDAQ: PBYI) is $6.12 last updated March 20, 2026 at 4:00 PM EDT.

Q

Does Puma Biotechnology (PBYI) pay a dividend?

A

There are no upcoming dividends for Puma Biotechnology.

Q

When is Puma Biotechnology (NASDAQ:PBYI) reporting earnings?

A

Puma Biotechnology does not have any upcoming earnings scheduled.

Q

Is Puma Biotechnology (PBYI) going to split?

A

There is no upcoming split for Puma Biotechnology.

Q

What sector and industry does Puma Biotechnology (PBYI) operate in?

A

Puma Biotechnology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch

Armata Pharmaceuticals Inc

Bicycle Therapeutics PLC

NASDAQ:BCYC

$4.39

0.92%

Silence Therapeutics PLC

NASDAQ:SLN

$6.17

%

Key Statistics

Open

$6.14

Close

$6.12

Volume / Avg.

340.27K / 430.72K

Day Range

$6.07 - $6.17

52 Wk Range

2.58 - 7.68

Market Cap

$308.39M

P/E Ratio

10.08

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

8.73%

Days to Cover

7.5

Recent Puma Biotechnology Inc News

Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute

A Delaware jury ordered AstraZeneca to pay Pfizer $107.5 million, ruling that AstraZeneca's lung cancer drug Tagrisso infringed on Pfizer's patents related to cancer treatment.

Vandana Singh

Takeda's Approved Blood Cancer Drug Hits Primary Goal In Newly-Diagnosed Patient Settings

Vandana Singh

Puma Biotech In-Licenses Takeda's Cancer Candidate With Primary Focus On Breast & Lung Cancer

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

41.80M

Investing Cash Flow (TTM)

-36.19M

Financing Cash Flow (TTM)

-45.20M

Free Cash Flow (TTM)

41.73M

Capital Expenditure (TTM)

-71.00K

Net Change in Cash (TTM)

-39.58M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$243.91M

PE Ratio (TTM)

10.08

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

1.36

PB Ratio (TTM)

2.40

Earnings Yield % (TTM)

9.92%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

4.57

Price / EBITDA (TTM)

5.84

Price / Free Cash Flow (TTM)

7.46

Book Value / Share

$2.56

Company Debt

Total Debt

$22.52M

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-$44.44M

Total Cash

$29.64M

Debt to Equity

0.22

Issuance of Debt (TTM)

-$44.44M

Repayment of Debt (TTM)

-$44.44M

Key Statistics

Open

$6.14

Close

$6.12

Volume / Avg.

340.27K / 430.72K

Day Range

$6.07 - $6.17

52 Wk Range

2.58 - 7.68

Market Cap

$308.39M

P/E Ratio

10.08

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

8.73%

Days to Cover

7.5

About

Sector

Health Care

Industry

Biotechnology

Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes inventive products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for t...

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry